These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 32868174

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. When should we start and stop ACEi/ARB in paediatric chronic kidney disease?
    Chan EY, Ma AL, Tullus K.
    Pediatr Nephrol; 2021 Jul; 36(7):1751-1764. PubMed ID: 33057769
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Hyperkalaemia-related reduction of RAASi treatment associates with more subsequent inpatient care.
    Svensson MK, Murohara T, Lesén E, Arnold M, Cars T, Järbrink K, Chen G, Morita N, Venkatesan S, Kanda E.
    Nephrol Dial Transplant; 2024 Jul 31; 39(8):1258-1267. PubMed ID: 38253386
    [Abstract] [Full Text] [Related]

  • 48. Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21 334 patients in the UK.
    Linde C, Qin L, Bakhai A, Furuland H, Evans M, Ayoubkhani D, Palaka E, Bennett H, McEwan P.
    ESC Heart Fail; 2019 Apr 31; 6(2):280-290. PubMed ID: 30629342
    [Abstract] [Full Text] [Related]

  • 49. Ambulatory Treatments for RAAS Inhibitor-Related Hyperkalemia and the 1-Year Risk of Recurrence.
    Hundemer GL, Talarico R, Tangri N, Leon SJ, Bota SE, Rhodes E, Knoll GA, Sood MM.
    Clin J Am Soc Nephrol; 2021 Mar 08; 16(3):365-373. PubMed ID: 33608262
    [Abstract] [Full Text] [Related]

  • 50. Pooled Analysis of Multiple Crossover Trials To Optimize Individual Therapy Response to Renin-Angiotensin-Aldosterone System Intervention.
    Petrykiv SI, Laverman GD, Persson F, Vogt L, Rossing P, de Borst MH, Gansevoort RT, de Zeeuw D, Heerspink HJL.
    Clin J Am Soc Nephrol; 2017 Nov 07; 12(11):1804-1813. PubMed ID: 29021336
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. [Hyperkalemia in heart failure: etiology, epidemiology and prognosis].
    Romani S, Sinagra G.
    G Ital Cardiol (Rome); 2021 Dec 07; 22(12 Suppl 1):e3-e7. PubMed ID: 34935773
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Hyperkalemia in the Hypertensive Patient.
    Lakkis JI, Weir MR.
    Curr Cardiol Rep; 2018 Mar 01; 20(2):12. PubMed ID: 29492706
    [Abstract] [Full Text] [Related]

  • 57. Hyperkalemia treatment modalities: A descriptive observational study focused on medication and healthcare resource utilization.
    Desai NR, Rowan CG, Alvarez PJ, Fogli J, Toto RD.
    PLoS One; 2020 Mar 01; 15(1):e0226844. PubMed ID: 31910208
    [Abstract] [Full Text] [Related]

  • 58. New Therapeutic Approaches for the Treatment of Hyperkalemia in Patients Treated with Renin-Angiotensin-Aldosterone System Inhibitors.
    Tamargo J, Caballero R, Delpón E.
    Cardiovasc Drugs Ther; 2018 Feb 01; 32(1):99-119. PubMed ID: 29372448
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.